Global Sepsis Biomarkers Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Sepsis Biomarkers Revenue
1.4 Market Analysis by Type
1.4.1 Global Sepsis Biomarkers Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Blood Biomarkers
1.4.3 Urine Biomarkers
1.5 Market by Application
1.5.1 Global Sepsis Biomarkers Market Share by Application: 2020 VS 2026
1.5.2 Diagnostics
1.5.3 Drug Discovery
1.5.4 Personalized Medicine
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Sepsis Biomarkers Market Perspective (2015-2026)
2.2 Sepsis Biomarkers Growth Trends by Regions
2.2.1 Sepsis Biomarkers Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Sepsis Biomarkers Historic Market Share by Regions (2015-2020)
2.2.3 Sepsis Biomarkers Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Sepsis Biomarkers Market Growth Strategy
2.3.6 Primary Interviews with Key Sepsis Biomarkers Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Sepsis Biomarkers Players by Market Size
3.1.1 Global Top Sepsis Biomarkers Players by Revenue (2015-2020)
3.1.2 Global Sepsis Biomarkers Revenue Market Share by Players (2015-2020)
3.1.3 Global Sepsis Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Sepsis Biomarkers Market Concentration Ratio
3.2.1 Global Sepsis Biomarkers Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Sepsis Biomarkers Revenue in 2019
3.3 Sepsis Biomarkers Key Players Head office and Area Served
3.4 Key Players Sepsis Biomarkers Product Solution and Service
3.5 Date of Enter into Sepsis Biomarkers Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Sepsis Biomarkers Historic Market Size by Type (2015-2020)
4.2 Global Sepsis Biomarkers Forecasted Market Size by Type (2021-2026)
5 Sepsis Biomarkers Breakdown Data by Application (2015-2026)
5.1 Global Sepsis Biomarkers Market Size by Application (2015-2020)
5.2 Global Sepsis Biomarkers Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Sepsis Biomarkers Market Size (2015-2020)
6.2 Sepsis Biomarkers Key Players in North America (2019-2020)
6.3 North America Sepsis Biomarkers Market Size by Type (2015-2020)
6.4 North America Sepsis Biomarkers Market Size by Application (2015-2020)
7 Europe
7.1 Europe Sepsis Biomarkers Market Size (2015-2020)
7.2 Sepsis Biomarkers Key Players in Europe (2019-2020)
7.3 Europe Sepsis Biomarkers Market Size by Type (2015-2020)
7.4 Europe Sepsis Biomarkers Market Size by Application (2015-2020)
8 China
8.1 China Sepsis Biomarkers Market Size (2015-2020)
8.2 Sepsis Biomarkers Key Players in China (2019-2020)
8.3 China Sepsis Biomarkers Market Size by Type (2015-2020)
8.4 China Sepsis Biomarkers Market Size by Application (2015-2020)
9 Japan
9.1 Japan Sepsis Biomarkers Market Size (2015-2020)
9.2 Sepsis Biomarkers Key Players in Japan (2019-2020)
9.3 Japan Sepsis Biomarkers Market Size by Type (2015-2020)
9.4 Japan Sepsis Biomarkers Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Sepsis Biomarkers Market Size (2015-2020)
10.2 Sepsis Biomarkers Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Sepsis Biomarkers Market Size by Type (2015-2020)
10.4 Southeast Asia Sepsis Biomarkers Market Size by Application (2015-2020)
11 India
11.1 India Sepsis Biomarkers Market Size (2015-2020)
11.2 Sepsis Biomarkers Key Players in India (2019-2020)
11.3 India Sepsis Biomarkers Market Size by Type (2015-2020)
11.4 India Sepsis Biomarkers Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Sepsis Biomarkers Market Size (2015-2020)
12.2 Sepsis Biomarkers Key Players in Central & South America (2019-2020)
12.3 Central & South America Sepsis Biomarkers Market Size by Type (2015-2020)
12.4 Central & South America Sepsis Biomarkers Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Thermo Fisher Scientific
13.1.1 Thermo Fisher Scientific Company Details
13.1.2 Thermo Fisher Scientific Business Overview and Its Total Revenue
13.1.3 Thermo Fisher Scientific Sepsis Biomarkers Introduction
13.1.4 Thermo Fisher Scientific Revenue in Sepsis Biomarkers Business (2015-2020))
13.1.5 Thermo Fisher Scientific Recent Development
13.2 Merck
13.2.1 Merck Company Details
13.2.2 Merck Business Overview and Its Total Revenue
13.2.3 Merck Sepsis Biomarkers Introduction
13.2.4 Merck Revenue in Sepsis Biomarkers Business (2015-2020)
13.2.5 Merck Recent Development
13.3 Bio-Rad Laboratories
13.3.1 Bio-Rad Laboratories Company Details
13.3.2 Bio-Rad Laboratories Business Overview and Its Total Revenue
13.3.3 Bio-Rad Laboratories Sepsis Biomarkers Introduction
13.3.4 Bio-Rad Laboratories Revenue in Sepsis Biomarkers Business (2015-2020)
13.3.5 Bio-Rad Laboratories Recent Development
13.4 QIAGEN
13.4.1 QIAGEN Company Details
13.4.2 QIAGEN Business Overview and Its Total Revenue
13.4.3 QIAGEN Sepsis Biomarkers Introduction
13.4.4 QIAGEN Revenue in Sepsis Biomarkers Business (2015-2020)
13.4.5 QIAGEN Recent Development
13.5 Roche
13.5.1 Roche Company Details
13.5.2 Roche Business Overview and Its Total Revenue
13.5.3 Roche Sepsis Biomarkers Introduction
13.5.4 Roche Revenue in Sepsis Biomarkers Business (2015-2020)
13.5.5 Roche Recent Development
13.6 Danaher Corporation
13.6.1 Danaher Corporation Company Details
13.6.2 Danaher Corporation Business Overview and Its Total Revenue
13.6.3 Danaher Corporation Sepsis Biomarkers Introduction
13.6.4 Danaher Corporation Revenue in Sepsis Biomarkers Business (2015-2020)
13.6.5 Danaher Corporation Recent Development
13.7 Siemens Healthcare
13.7.1 Siemens Healthcare Company Details
13.7.2 Siemens Healthcare Business Overview and Its Total Revenue
13.7.3 Siemens Healthcare Sepsis Biomarkers Introduction
13.7.4 Siemens Healthcare Revenue in Sepsis Biomarkers Business (2015-2020)
13.7.5 Siemens Healthcare Recent Development
13.8 Abbott
13.8.1 Abbott Company Details
13.8.2 Abbott Business Overview and Its Total Revenue
13.8.3 Abbott Sepsis Biomarkers Introduction
13.8.4 Abbott Revenue in Sepsis Biomarkers Business (2015-2020)
13.8.5 Abbott Recent Development
13.9 GenMark Diagnostics
13.9.1 GenMark Diagnostics Company Details
13.9.2 GenMark Diagnostics Business Overview and Its Total Revenue
13.9.3 GenMark Diagnostics Sepsis Biomarkers Introduction
13.9.4 GenMark Diagnostics Revenue in Sepsis Biomarkers Business (2015-2020)
13.9.5 GenMark Diagnostics Recent Development
13.10 HiMedia Laboratories
13.10.1 HiMedia Laboratories Company Details
13.10.2 HiMedia Laboratories Business Overview and Its Total Revenue
13.10.3 HiMedia Laboratories Sepsis Biomarkers Introduction
13.10.4 HiMedia Laboratories Revenue in Sepsis Biomarkers Business (2015-2020)
13.10.5 HiMedia Laboratories Recent Development
13.11 Immunexpress
10.11.1 Immunexpress Company Details
10.11.2 Immunexpress Business Overview and Its Total Revenue
10.11.3 Immunexpress Sepsis Biomarkers Introduction
10.11.4 Immunexpress Revenue in Sepsis Biomarkers Business (2015-2020)
10.11.5 Immunexpress Recent Development
13.12 Abionic
10.12.1 Abionic Company Details
10.12.2 Abionic Business Overview and Its Total Revenue
10.12.3 Abionic Sepsis Biomarkers Introduction
10.12.4 Abionic Revenue in Sepsis Biomarkers Business (2015-2020)
10.12.5 Abionic Recent Development
13.13 T2 Biosystems
10.13.1 T2 Biosystems Company Details
10.13.2 T2 Biosystems Business Overview and Its Total Revenue
10.13.3 T2 Biosystems Sepsis Biomarkers Introduction
10.13.4 T2 Biosystems Revenue in Sepsis Biomarkers Business (2015-2020)
10.13.5 T2 Biosystems Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of TablesTable 1. Sepsis Biomarkers Key Market Segments
Table 2. Key Players Covered: Ranking by Sepsis Biomarkers Revenue
Table 3. Ranking of Global Top Sepsis Biomarkers Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Sepsis Biomarkers Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Blood Biomarkers
Table 6. Key Players of Urine Biomarkers
Table 7. Global Sepsis Biomarkers Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Sepsis Biomarkers Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Sepsis Biomarkers Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Sepsis Biomarkers Market Share by Regions (2015-2020)
Table 11. Global Sepsis Biomarkers Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Sepsis Biomarkers Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Sepsis Biomarkers Market Growth Strategy
Table 17. Main Points Interviewed from Key Sepsis Biomarkers Players
Table 18. Global Sepsis Biomarkers Revenue by Players (2015-2020) (Million US$)
Table 19. Global Sepsis Biomarkers Market Share by Players (2015-2020)
Table 20. Global Top Sepsis Biomarkers Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sepsis Biomarkers as of 2019)
Table 21. Global Sepsis Biomarkers by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Sepsis Biomarkers Product Solution and Service
Table 24. Date of Enter into Sepsis Biomarkers Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Sepsis Biomarkers Market Size by Type (2015-2020) (Million US$)
Table 27. Global Sepsis Biomarkers Market Size Share by Type (2015-2020)
Table 28. Global Sepsis Biomarkers Revenue Market Share by Type (2021-2026)
Table 29. Global Sepsis Biomarkers Market Size Share by Application (2015-2020)
Table 30. Global Sepsis Biomarkers Market Size by Application (2015-2020) (Million US$)
Table 31. Global Sepsis Biomarkers Market Size Share by Application (2021-2026)
Table 32. North America Key Players Sepsis Biomarkers Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Sepsis Biomarkers Market Share (2019-2020)
Table 34. North America Sepsis Biomarkers Market Size by Type (2015-2020) (Million US$)
Table 35. North America Sepsis Biomarkers Market Share by Type (2015-2020)
Table 36. North America Sepsis Biomarkers Market Size by Application (2015-2020) (Million US$)
Table 37. North America Sepsis Biomarkers Market Share by Application (2015-2020)
Table 38. Europe Key Players Sepsis Biomarkers Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Sepsis Biomarkers Market Share (2019-2020)
Table 40. Europe Sepsis Biomarkers Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Sepsis Biomarkers Market Share by Type (2015-2020)
Table 42. Europe Sepsis Biomarkers Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Sepsis Biomarkers Market Share by Application (2015-2020)
Table 44. China Key Players Sepsis Biomarkers Revenue (2019-2020) (Million US$)
Table 45. China Key Players Sepsis Biomarkers Market Share (2019-2020)
Table 46. China Sepsis Biomarkers Market Size by Type (2015-2020) (Million US$)
Table 47. China Sepsis Biomarkers Market Share by Type (2015-2020)
Table 48. China Sepsis Biomarkers Market Size by Application (2015-2020) (Million US$)
Table 49. China Sepsis Biomarkers Market Share by Application (2015-2020)
Table 50. Japan Key Players Sepsis Biomarkers Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Sepsis Biomarkers Market Share (2019-2020)
Table 52. Japan Sepsis Biomarkers Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Sepsis Biomarkers Market Share by Type (2015-2020)
Table 54. Japan Sepsis Biomarkers Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Sepsis Biomarkers Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Sepsis Biomarkers Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Sepsis Biomarkers Market Share (2019-2020)
Table 58. Southeast Asia Sepsis Biomarkers Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Sepsis Biomarkers Market Share by Type (2015-2020)
Table 60. Southeast Asia Sepsis Biomarkers Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Sepsis Biomarkers Market Share by Application (2015-2020)
Table 62. India Key Players Sepsis Biomarkers Revenue (2019-2020) (Million US$)
Table 63. India Key Players Sepsis Biomarkers Market Share (2019-2020)
Table 64. India Sepsis Biomarkers Market Size by Type (2015-2020) (Million US$)
Table 65. India Sepsis Biomarkers Market Share by Type (2015-2020)
Table 66. India Sepsis Biomarkers Market Size by Application (2015-2020) (Million US$)
Table 67. India Sepsis Biomarkers Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Sepsis Biomarkers Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Sepsis Biomarkers Market Share (2019-2020)
Table 70. Central & South America Sepsis Biomarkers Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Sepsis Biomarkers Market Share by Type (2015-2020)
Table 72. Central & South America Sepsis Biomarkers Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Sepsis Biomarkers Market Share by Application (2015-2020)
Table 74. Thermo Fisher Scientific Company Details
Table 75. Thermo Fisher Scientific Business Overview
Table 76. Thermo Fisher Scientific Product
Table 77. Thermo Fisher Scientific Revenue in Sepsis Biomarkers Business (2015-2020) (Million US$)
Table 78. Thermo Fisher Scientific Recent Development
Table 79. Merck Company Details
Table 80. Merck Business Overview
Table 81. Merck Product
Table 82. Merck Revenue in Sepsis Biomarkers Business (2015-2020) (Million US$)
Table 83. Merck Recent Development
Table 84. Bio-Rad Laboratories Company Details
Table 85. Bio-Rad Laboratories Business Overview
Table 86. Bio-Rad Laboratories Product
Table 87. Bio-Rad Laboratories Revenue in Sepsis Biomarkers Business (2015-2020) (Million US$)
Table 88. Bio-Rad Laboratories Recent Development
Table 89. QIAGEN Company Details
Table 90. QIAGEN Business Overview
Table 91. QIAGEN Product
Table 92. QIAGEN Revenue in Sepsis Biomarkers Business (2015-2020) (Million US$)
Table 93. QIAGEN Recent Development
Table 94. Roche Company Details
Table 95. Roche Business Overview
Table 96. Roche Product
Table 97. Roche Revenue in Sepsis Biomarkers Business (2015-2020) (Million US$)
Table 98. Roche Recent Development
Table 99. Danaher Corporation Company Details
Table 100. Danaher Corporation Business Overview
Table 101. Danaher Corporation Product
Table 102. Danaher Corporation Revenue in Sepsis Biomarkers Business (2015-2020) (Million US$)
Table 103. Danaher Corporation Recent Development
Table 104. Siemens Healthcare Company Details
Table 105. Siemens Healthcare Business Overview
Table 106. Siemens Healthcare Product
Table 107. Siemens Healthcare Revenue in Sepsis Biomarkers Business (2015-2020) (Million US$)
Table 108. Siemens Healthcare Recent Development
Table 109. Abbott Business Overview
Table 110. Abbott Product
Table 111. Abbott Company Details
Table 112. Abbott Revenue in Sepsis Biomarkers Business (2015-2020) (Million US$)
Table 113. Abbott Recent Development
Table 114. GenMark Diagnostics Company Details
Table 115. GenMark Diagnostics Business Overview
Table 116. GenMark Diagnostics Product
Table 117. GenMark Diagnostics Revenue in Sepsis Biomarkers Business (2015-2020) (Million US$)
Table 118. GenMark Diagnostics Recent Development
Table 119. HiMedia Laboratories Company Details
Table 120. HiMedia Laboratories Business Overview
Table 121. HiMedia Laboratories Product
Table 122. HiMedia Laboratories Revenue in Sepsis Biomarkers Business (2015-2020) (Million US$)
Table 123. HiMedia Laboratories Recent Development
Table 124. Immunexpress Company Details
Table 125. Immunexpress Business Overview
Table 126. Immunexpress Product
Table 127. Immunexpress Revenue in Sepsis Biomarkers Business (2015-2020) (Million US$)
Table 128. Immunexpress Recent Development
Table 129. Abionic Company Details
Table 130. Abionic Business Overview
Table 131. Abionic Product
Table 132. Abionic Revenue in Sepsis Biomarkers Business (2015-2020) (Million US$)
Table 133. Abionic Recent Development
Table 134. T2 Biosystems Company Details
Table 135. T2 Biosystems Business Overview
Table 136. T2 Biosystems Product
Table 137. T2 Biosystems Revenue in Sepsis Biomarkers Business (2015-2020) (Million US$)
Table 138. T2 Biosystems Recent Development
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Sepsis Biomarkers Market Share by Type: 2020 VS 2026
Figure 2. Blood Biomarkers Features
Figure 3. Urine Biomarkers Features
Figure 4. Global Sepsis Biomarkers Market Share by Application: 2020 VS 2026
Figure 5. Diagnostics Case Studies
Figure 6. Drug Discovery Case Studies
Figure 7. Personalized Medicine Case Studies
Figure 8. Others Case Studies
Figure 9. Sepsis Biomarkers Report Years Considered
Figure 10. Global Sepsis Biomarkers Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Sepsis Biomarkers Market Share by Regions: 2020 VS 2026
Figure 12. Global Sepsis Biomarkers Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Sepsis Biomarkers Market Share by Players in 2019
Figure 15. Global Top Sepsis Biomarkers Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sepsis Biomarkers as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Sepsis Biomarkers Revenue in 2019
Figure 17. North America Sepsis Biomarkers Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Sepsis Biomarkers Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Sepsis Biomarkers Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Sepsis Biomarkers Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Sepsis Biomarkers Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Sepsis Biomarkers Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Sepsis Biomarkers Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Thermo Fisher Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Thermo Fisher Scientific Revenue Growth Rate in Sepsis Biomarkers Business (2015-2020)
Figure 26. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Merck Revenue Growth Rate in Sepsis Biomarkers Business (2015-2020)
Figure 28. Bio-Rad Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Bio-Rad Laboratories Revenue Growth Rate in Sepsis Biomarkers Business (2015-2020)
Figure 30. QIAGEN Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. QIAGEN Revenue Growth Rate in Sepsis Biomarkers Business (2015-2020)
Figure 32. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Roche Revenue Growth Rate in Sepsis Biomarkers Business (2015-2020)
Figure 34. Danaher Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Danaher Corporation Revenue Growth Rate in Sepsis Biomarkers Business (2015-2020)
Figure 36. Siemens Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Siemens Healthcare Revenue Growth Rate in Sepsis Biomarkers Business (2015-2020)
Figure 38. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Abbott Revenue Growth Rate in Sepsis Biomarkers Business (2015-2020)
Figure 40. GenMark Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. GenMark Diagnostics Revenue Growth Rate in Sepsis Biomarkers Business (2015-2020)
Figure 42. HiMedia Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. HiMedia Laboratories Revenue Growth Rate in Sepsis Biomarkers Business (2015-2020)
Figure 44. Immunexpress Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Immunexpress Revenue Growth Rate in Sepsis Biomarkers Business (2015-2020)
Figure 46. Abionic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Abionic Revenue Growth Rate in Sepsis Biomarkers Business (2015-2020)
Figure 48. T2 Biosystems Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. T2 Biosystems Revenue Growth Rate in Sepsis Biomarkers Business (2015-2020)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed